← Leaderboards
Jon O Nagy
Ligocyte Pharmaceuticals, Inc.
$9,865,975
Attributed
$13,256,799
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,256,799 · 9
By mechanism
R44$7,005,730 · 3
U44$2,615,455 · 1
R42$2,400,000 · 1
R43$756,136 · 2
R41$479,478 · 2
Top collaborators
- Timothy J. Triche7 shared
- Joyce Y Wong3 shared
- Charles Thompson1 shared
Others in their field
Top investigators on “Polymers”
- Marc A Hillmyer · University Of Minnesota-Twin Cities$45,350,238
- Michael F Rubner · Massachusetts Institute Of Technology$44,168,921
- Nicholas Hud · Emory University$41,051,104
- Timothy P Lodge · Gordon Research Conferences$40,942,324
- Eric Baer · Case Western Reserve University$37,476,250
- Robert S Langer · Massachusetts Institute Of Technology$29,222,504
Research focus
PolymersTechnologyBaseSmall Business Innovation Research GrantResponseFormulationAntibodiesTissuesSafetySuccessProgramsAnimalsLiposomesBindingToxic EffectSmall MoleculeNanoparticlePharmaceutical PreparationsDetectionEncapsulatedCytotoxic AgentChemotherapeutic AgentChemotherapyExposure To
Grant awards (21)
Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)$1,000,000
R42 · FY2025 · CA · contact PI
Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)$1,000,000
R42 · FY2024 · CA · contact PI
Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)$400,000
R42 · FY2023 · CA · contact PI
NV103: Antibody Conjugated Nanoparticle for Ewing Sarcoma Targeted Therapy$892,769
R44 · FY2020 · CA · contact PI
NV103: Antibody Conjugated Nanoparticle for Ewing Sarcoma Targeted Therapy$1,019,254
R44 · FY2019 · CA · contact PI
Targeted Polymerized Shell Microbubbles to Image and Treat Surgical Adhesions$759,290
R44 · FY2019 · GM · contact PI
Targeted Polymerized Shell Microbubbles to Image and Treat Surgical Adhesions$831,190
R44 · FY2018 · GM · contact PI
NV103: Antibody Conjugated Nanoparticle for Ewing Sarcoma Targeted Therapy$240,749
R44 · FY2018 · CA · contact PI
Nanoparticle Delivery System for Ewing Sarcoma Treatment$240,750
R41 · FY2016 · CA · contact PI
Targeted Polymerized Shell Microbubbles to Image Surgical Adhesions$238,728
R41 · FY2016 · GM
Nanoparticle Defense for Agrichemical Exposures$158,919
R43 · FY2012 · ES · contact PI
Development of a selective biosensor for detecting organophosphate exposure$762,618
U44 · FY2009 · NS · contact PI
Development of a selective biosensor for detecting organophosphate exposure$728,259
U44 · FY2008 · NS · contact PI
Development of a selective biosensor for detecting organophosphate pesticide expo$298,532
R43 · FY2008 · ES · contact PI
Development of a selective biosensor for detecting organophosphate exposure$75,000
U44 · FY2008 · NS · contact PI
Development of a selective biosensor for detecting organophosphate exposure$749,037
U44 · FY2007 · NS · contact PI
Development of a selective biosensor for detecting organophosphate pesticide expo$298,685
R43 · FY2007 · ES · contact PI
Development of a selective biosensor for detecting organophosphate exposure$300,541
U44 · FY2006 · NS · contact PI
RATIONAL DESIGN OF ADHESION BLOCKING ANTI-INFLAMMATORIES$517,972
R44 · FY2002 · AI
RATIONAL DESIGN OF ADHESION BLOCKING ANTI-INFLAMMATORIES$1,450,152
R44 · FY2001 · AI
RATIONAL DESIGN OF ADHESION BLOCKING ANTI-INFLAMMATORIES$1,294,354
R44 · FY2000 · AI